ADARx Pharmaceuticals, Inc. (ADRX): 4 filed Sep 29, 2026

Form type
4
Filing date
Sep 29, 2026
Accession number
0001193125-26-408061
Filer
ADARx Pharmaceuticals, Inc. (CIK 1802369)